CD155 in tumor progression and targeted therapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference141 articles.
1. Poliovirus Receptor: more than a simple viral receptor;Bowers;Virus Res.,2017
2. Cellular receptor for poliovirus: molecular Cloning,Nucleotide sequence, and expression of a new allember of the immunoglobulin superfamily;Cathy;Cell,1989
3. CD155: a multi-functional molecule in tumor progression;Molfetta;Int. J. Mol. Sci.,2020
4. Tumor intrinsic and extrinsic immune functions of CD155;O'Donnell;Semin. Cancer Biol.,2020
5. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy;Wu;J. Exp. Clin. Cancer Res.,2021
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment;Aging;2024-08-07
2. Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy;Science China Life Sciences;2024-02-01
3. CD155 is essential for skeletal muscle regeneration by regulating satellite cell proliferation and differentiation;The FASEB Journal;2024-01-22
4. Targeting TIGIT for cancer immunotherapy: recent advances and future directions;Biomarker Research;2024-01-16
5. Poliovirus receptor–based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma;JNCI: Journal of the National Cancer Institute;2023-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3